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ABSTRACT 
Objectives 
External Ventricular Drain (EVD) insertion is a common neurosurgical procedure. EVD-
related infection (ERI) is a major complication that can lead to morbidity and mortality. In 
this study, we aimed to establish a national ERI rate in the United Kingdom (UK) and Ireland 
and determine key factors influencing the infection risk.  
 
Methods 
A prospective multi-centre cohort study of EVD insertions in 21 neurosurgical units was 
performed over 6 months. The primary outcome measure was 30-day ERI. A Cox Regression 
Model was used for multivariate analysis to calculate Hazard Ratios (HR).  
 
Results 
A total of 495 EVD catheters were inserted into 452 patients with EVDs remaining in-situ for 
4700 days (median 8 days; interquartile range 4-13). Of the catheters inserted, 188 (38%) 
were antibiotic-impregnated, 161 (32.5%) were plain and 146 (29.5%) were silver-bearing. A 
total of 46 ERIs occurred giving an infection risk of 9.3%. Cox regression analysis 
demonstrated that factors independently associated with increased infection risk included 
duration of EVD placement for ≥8 days [HR=2.47 (1.12-5.45); p=0.03], regular sampling 
(daily sampling [HR=4.73 (1.28-17.42), p=0.02] and alternate day sampling [HR=5.28 (2.25-
12.38); p<0.01]). There was no association between catheter type or tunnelling distance and 
ERI.  
 
Conclusions 
In the UK and Ireland, the ERI rate was 9.3% during the study period. The study 
demonstrated that EVDs left in situ for ≥8 days and those sampled more frequently were 
associated with a higher risk of infection. Importantly, the study showed no significant 
difference in ERI risk between different catheter types.  
 
Keywords 
External ventricular drainage; infection; impregnated catheter; multicentre study 
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INTRODUCTION 
The insertion of an external ventricular drain (EVD) is one of the commonest neurosurgical 
procedures. It was first described by Claude-Nicholas Le Cat in 1744 when he punctured the 
ventricle and left a wick in-situ for congenital hydrocephalus.[1] Since then, the procedure 
has seen significant refinement in its technique, an expansion of its indications and 
technological advances in the materials used for drainage and insertion.[2] In the last two 
decades, EVD research has focused on improving the accuracy of ventricular access and 
infection control. EVD related infection (ERI) is a significant complication that can lead to 
increased morbidity and healthcare costs.[3] ERI has a reported rate in the literature between 
1% and 45%.[4] This wide variation is driven by differing definitions of ERI and study 
methodology. A range of factors are reported to be associated with increased ERI risk 
including duration of drainage, cerebrospinal fluid (CSF) leak, frequency of sampling and 
underlying aetiology.[4–8] Efforts to reduce ERI risk have included the introduction of EVD 
care bundles, the use of peri-operative or continuous prophylactic antibiotics and the 
development of antimicrobial-impregnated catheters.[5,9–11] Observational studies of ERI 
rates have been primarily retrospective and those which collected data prospectively have 
been restricted to single neurosurgical units.[4,12–16] Studies with these limitations have 
inherent practice and selection biases, do not accurately reflect current national practice for 
generating health economic models, nor do they lend themselves to generating a baseline 
against which future multicentre randomized trials can be designed and adequately powered. 
Using prospectively collected data from multiple neurosurgical units, we aimed to determine 
the national infection rate, assess the incorporation of current evidence into clinical practice 
and identify parameters associated with increased infection rates that can be interrogated in 
future clinical studies and be used to target preventative measures.  
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MATERIALS AND METHODS 
A prospective, multi-centre observational study of EVD management and infection rates was 
conducted across 21 neurosurgical units in the United Kingdom and Ireland. Primary data 
collection took place over 6 months between November 2014 and May 2015 followed by 30-
day follow-up. The inclusion criteria were any tunnelled EVD catheter inserted in a patient of 
any age without evidence of pre-existing CSF infection. The study protocol was approved by 
the Society of British Neurological Surgeons (SBNS) Academic Committee and conducted 
by the British Neurosurgical Trainee Research Collaborative (BNTRC).[17] Strengthening 
the Reporting of Observational Studies in Epidemiology (STROBE) checklist was used to 
guide the preparation of this manuscript.[18]  
 
Data Collection and Outcome Measures 
The BNTRC is a network of neurosurgical trainees in the United Kingdom and Ireland who 
conduct multi-centre collaborative research with the support of the academic committee of 
the Society of British Neurological Surgeons.[19,20] Within each neurosurgical unit (NSU), 
a trainee lead coordinated local patient identification and data collection working closely with 
a team of collaborators, including a Consultant lead. Data were entered to the Outcome 
Registry Intervention and Operation Network (ORION) based at the University of 
Cambridge. ORION is a secure database, which complies with the Department of Health 
Information Governance policy and meets data security standards of the Information 
Governance Toolkit of the Health and Social Care Information Centre. The study protocol 
was approved by the audit & clinical governance committee of each participating hospital.  
 
A range of demographic and operative parameters were captured including age, sex, 
underlying aetiology, primary surgeon grade, type of catheter (plain, antibiotic-impregnated, 
or silver-bearing), length of tunnelling and frequency of subsequent CSF sampling protocol 
(daily, alternate days, 1-2 times per week, no sampling and unknown). The primary outcome 
was EVD-related infection (ERI) within 30 days. A pragmatic definition of ERI was used: 
evidence of positive CSF culture (and/or gram stain) or clinical suspicion of ERI by 
managing team due to CSF pleocytosis, elevated serum inflammatory markers and clinical 
signs including pyrexia, meningism and altered conscious level.[21] Secondary outcome 
measures included: mortality in the neurosurgical unit (NSU), functional status at discharge 
using the modified Rankin Score (mRS) and permanent CSF diversion at 30 days. 
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Statistical Analysis 
The statistical approach follows the principles outlined in the study protocol.[17] In the 
univariate analyses, Chi-squared test or Fisher’s exact test was used to compare clinical 
variables between infected and non-infected cases, and outcomes between different types of 
catheters. The duration of prophylactic antibiotic therapy and time to infection were 
compared using the Kruskal-Wallis test. In the multivariate analyses of ERIs, pre-specified 
independent variables were entered which included type of catheter, length of tunnelling, 
CSF sampling frequency, and dichotomised duration of EVD use around the median. These 
were chosen because of their known or hypothesised association with ERI. To examine the 
rate of ERIs, hazard ratios for ERI were calculated using Cox regression model adjusted for 
age, sex, type of catheter, length of tunnelling, CSF sampling frequency and dichotomised 
duration of EVD use. The time-at-risk period was from date of EVD insertion to ERI, death 
or 30 days after EVD insertion. To examine factors associated with ERIs a multiple logistic 
regression model using the pre-specified independent variables was used. As a sensitivity 
analysis to test whether NSU influenced the odds of infection within 30 days of EVD 
insertion, a multilevel mixed effect logistic regression was performed using hospitals as 
clusters. This model was compared to a single-level multiple logistic regression model using 
the likelihood ratio test. We used STATA 13.0 (StataCorp) for conducting statistical tests and 
generating graphical outputs. A p-value of <0.05 denoted statistical significance. 
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RESULTS 
Demographic and operative data 
During the 6-month period, a total of 495 EVD catheters were inserted in 452 patients. The 
follow-up was 12308 days (median 30 days; interquartile range [IQR] 23-30). The median 
age at time of insertion was 54 years and 261 (52.7%) catheters were inserted in female 
patients. Hydrocephalus secondary to a neurovascular aetiology (64.9%) was the commonest 
indication for EVD insertion followed by tumours (17.8%) and trauma (7.1%). The baseline 
demographic characteristics of the cohort are presented in Table 1.  
 
Patient characteristics No. % 
Age   
Mean (SD) 51.8 (19.2) - 
Median (IQR) 54 (41-67) - 
Age-groups   
0-17 37 7.4 
18-29 34 6.8 
30-39 45 9.1 
40-49 78 15.8 
50-59 113 22.8 
60-69 103 20.8 
70-79 66 13.3 
80-89 15 3.0 
90+ 4 1.0 
Gender   
Female 261 52.7 
Male 234 47.3 
Pathology    
Congenital, IIH & NPH 12 2.4 
Shunt dysfunction 19 3.8 
Neurovascular 321 64.9 
Other 20 4.0 
Trauma 35 7.1 
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Tumour 88 17.8 
Pre-operative ASA status   
1 117 23.6 
2 108 21.8 
3 111 22.4 
4 131 26.5 
5 28 5.7 
Table 1: Demographic data for 495 EVD catheters 
SD=standard deviation; IQR=interquartile range; IIH=Idiopathic Intracranial Hypertension; 
NPH=Normal Pressure Hydrocephalus; ASA=American Society of Anaesthesiologists 
 
The majority (98.6%) of EVDs were inserted in the operating theatre and the remainder 
(1.4%) were inserted in the intensive care unit (ICU). In most cases (85.3%) prophylactic 
systemic antibiotics were given at induction. A small number (3.2%) had prolonged systemic 
antibiotic prophylaxis with the remaining groups either already on antibiotics (3.8%) or 
receiving no systemic antimicrobial prophylaxis (7.7%). Neurosurgical trainees were the 
primary surgeon in 424 (85.7%) EVD procedures with 66% of the total being inserted by 
senior trainees. Of the catheters inserted, 188 (38%) were antibiotic-impregnated, 161 
(32.5%) were plain and 146 (29.5%) were silver-bearing catheters. EVDs remained in-situ for 
a total of 4700 days [median of 8 days (IQR 4-13)]. Table 2 presents operative data regarding 
the EVD procedures.  
 
Operative characteristics No. % 
Length of tunnelling   
0-5cm 119 24.0 
5-10cm 359 72.5 
>10cm 17 3.4 
Post-operative CT head scan   
No 100 20.2 
Yes 395 79.8 
CSF sampling frequency   
No sampling 129 26.1 
1-2 times per week 234 47.3 
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Alternate days 24 4.9 
Daily 7 1.4 
Unknown 101 20.4 
Catheter type   
Plain 161 32.5 
Antibiotic-impregnated 188 38 
Silver-bearing 146 29.5 
Primary surgeon   
Intern/Foundation doctor 5 1.0 
Junior neurosurgery trainee 97 19.6 
Senior neurosurgery trainee 327 66.1 
Consultant/Attending 66 13.3 
Table 2: Operative data for 495 EVD catheters 
 
Infection outcome 
Infection rate 
Forty-six ERIs were observed during the follow-up period. The overall risk of infection was 
9.3% (n=46/495) within 30 days.  One ERI had a missing date of infection. Of the remaining 
45 ERIs, 6 occurred after EVD removal. Therefore, the rate of ERI while an EVD was in 
place was 0.8% per day.  The median time to infection was 9 days (IQR 5-15). For 25 cases 
of ERI, pathogens were isolated with a total of 29 organisms. The commonest organisms 
were coagulase negative staphylococcus (n=10, 34.5%), followed by Staphylococcus aureus 
(n=6, 20.7%) and Enterococcus spp (n=3, 10.3%). Table 3 includes the frequency of all 
isolated microbiological organisms.  
 
Cultured organisms No % 
Coagulase negative staphylococcus* 10 34.5 
Staphylococcus aureus 6 20.7 
Enterococcus spp 3 10.3 
Enterobacter spp 2 6.9 
Klebsiella pneumoniae 2 6.9 
Morganella morganii 1 3.4 
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Escherichia coli 1 3.4 
Klebsiella sp. 1 3.4 
Pseudomonas aeruginosa 1 3.4 
Corynebacterium sp. 1 3.4 
Streptococcus sp. 1 3.4 
Table 3: List of organisms cultured from CSF samples 
* 3 cases due to Staphylococcus epidermidis 
 
The median length of treatment with antibiotics was 10 days (IQR 7-14). A comparison of 
infected versus uninfected cases using the Chi-squared test demonstrated that a significantly 
higher percentage of infected cases had a catheter in-situ for ≥8 days (77.8%) compared to 
uninfected cases (47.3%) [p <0.01]. Similarly, a significantly higher percentage of infected 
cases had their EVD sampled more frequently (daily or on alternate days) compared to 
uninfected cases [p<0.01]. Conversely, there was no significant difference between infected 
and uninfected cases with regard to the different catheter types [p=0.31], length of tunnelling 
[p=0.71] or the likelihood of permanent CSF diversion at 30 days [p=0.91]. Table 4 provides 
comparison between the infected and uninfected cases. 
 
 Infection within 30 days  
 No (%) Yes (%) p-value 
Catheter Type    
Plain  149 (92.5) 12 (7.5) 0.314 
Antibiotic-impregnated  174 (92.6) 14 (7.4)  
Silver-bearing  126 (86.3) 20 (13.7)  
CSF sampling frequency    
No sampling 129 (100) 0 (0) <0.01 
1-2 times per week 211 (90.2) 23 (9.8)  
Alternate days 15 (62.5) 9 (26.5)  
Daily 3 (42.9) 4 (57.1)  
Unknown 91 (90.1) 10 (9.9)  
Length of tunnelling    
0-5cm 106 (89.1) 13 (10.9) 0.71 
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5-10cm 328 (91.4) 31 (8.6)  
>10cm 15 (88.2) 2 (11.8)  
Primary surgeon    
Intern/Foundation doctor 4 (80.0) 1 (20.0) 0.25 
Junior neurosurgery trainee 87 (89.7) 10 (10.3)  
Senior neurosurgery trainee 294 (89.9) 33 (10.1)  
Consultant 64 (97.0) 2 (3.0)  
Duration of EVD use*    
0-7 days 236 (95.9) 10 (4.1) <0.01 
8+ days 212 (85.8) 35 (14.2)  
CSF diversion    
Permanent CSF diversion 71 (91.0) 7 (9.0) 0.91 
No permanent diversion 378 (90.6) 39 (9.4)  
Table 4: Comparison between infected and uninfected catheters. Comparisons made using 
chi-square test.  
* 2 cases excluded as no valid exit date 
 
Comparison between EVD catheter types infection outcome 
A chi-squared test for homogeneity showed there was no significant difference between the 
distribution of catheter types across the cohort age groups, gender and underlying pathology. 
A comparison of the infection rate according to catheter types showed that silver-bearing 
catheters had the highest infection rate (13.7%), compared to plain (7.5%) and antibiotic-
impregnated catheters (7.4%), but this did not reach statistical significance [p=0.09]. The 
median time to infection was longest for the antibiotic-impregnated catheters (11 days) 
followed by plain catheters (8 days) and then silver-bearing (7 days). Infections on a 
background of antibiotic-impregnated catheters received antibiotic treatment for a median of 
14 days, silver-bearing catheters received a median of 10 days’ therapy and plain catheters 
received 7.5 days. Table 5 provides a summary of clinical and infection variation between 
the catheter subtypes.  
 
 
Plain 
(n=161) 
Antibiotic-
impregnated 
(n=188) 
Silver-bearing 
(n=146) 
p-
value 
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 No % No % No %  
30-day infection         
No 149 92.6 174 92.6 126 86.3 0.09 
Yes 12 7.5 14 7.4 20 13.7  
Time to infection 
(median) 
       
 8 (1-
29) 
- 11 (2-
29) 
- 7 (1-
39) 
- 0.19 
Length of antibiotic 
therapy for ERI 
(median) 
       
 7.5 (1-
28) 
- 14 (1-
87) 
- 10 (1-
37) 
- 0.23 
Cultured 
microorganisms 
       
Coagulase negative 
staphylococcus (p) 
4 36.3 2 25.0 4 40.0 - 
Staphylococcus aureus 
(p) 
3 27.3 2 25.0 1 10.0 - 
Enterococcus spp (p) 1 9.1 2 25.0 - - - 
Enterobacter spp (n) - - 1 12.5 1 10.0 - 
Klebsiella pneumoniae 
(n) 
1 9.1 - - 1 10.0 - 
Morganella morganii 
(n) 
- - - - 1 10.0 - 
Escherichia coli (n) 1 9.1 - - - - - 
Klebsiella (n) 1 9.1 - - - - - 
Pseudomonas 
aeruginosa (n) 
- - - - 1 10.0 - 
Corynebacterium (p) - - 1 12.5 - - - 
Streptococcus spp (p) - - - - 1 10.0 - 
30-day mortality*        
No 100 70.4 145 81.0 93 71.0 0.05 
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Yes 42 29.6 34 19.0 38 29.0  
30-day mRS*        
Good (mRS 0-2) 50 35.2 79 44.1 35 26.7 0.01 
Poor (mRS 3-5) 50 35.2 66 36.9 58 44.3  
Death 42 29.6 34 19.0 38 29.0  
Table 5: Comparison of clinical and infection parameters between catheter subtypes.  
*30-day mortality and 30-day mRS (modified Rankin Score) based on 452 non-duplicate 
patients; (p) = gram stain positive; (n) = gram stain negative 
 
Clinical variables associated with infection  
There was a significant increase in risk of infection for both daily and alternate day sampling 
regimens compared to catheters that were sampled 1-2 times per week. Similarly, catheters 
left in situ for >8 days had a higher risk of ERI compared to those removed at 7 days or less 
[OR=2.54 (95% CI 1.14-5.7); p=0.02]. There was no association between the underlying 
pathology and the risk of infection in univariate analysis (p=0.76). Catheters tunnelled >5cm 
had an ERI odds ratio of 0.75 [(95% CI 0.3-1.45); p=0.29] compared to those with shorter 
tunnelling. Nelson-Aalen cumulative hazard estimate curves of catheter type, EVD duration 
and length of tunnelling are shown in Figure 1. To determine whether NSU had an effect on 
ERI, a likelihood ratio test, comparing a multilevel mixed effects logistic regression using 
hospitals as clusters, was performed; ERI rate did not significantly vary between hospitals 
(p=0.16). A Cox regression model adjusted for age, sex, type of catheter, length of tunnelling, 
CSF sampling frequency, and duration of EVD use based on 441 EVDs where time-at-risk 
was available identified a higher rate of infection for catheters kept in-situ for 8 days or 
longer [HR=2.47 (95% CI 1.12-5.45); p=0.03]. Using a similar analysis, there was no 
significant difference in ERI risk between catheter types (Table 6). 
 
 Hazard ratio 95% CI p-value 
Catheter type    
Plain Ref - - 
Antibiotic-impregnated 0.87 0.37-2.03 0.75 
Silver-bearing 1.35 0.63-2.88 0.44 
Length of tunnelling    
0-5cm Ref - - 
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>5cm 0.75 0.36-1.55 0.44 
CSF sampling frequency    
1-2 times per week Ref - - 
Alternate days 5.28 2.25-12.38 <0.01 
Daily 4.73 1.28-17.42 0.02 
Unknown 1.26 0.56-2.82 0.58 
Duration of EVD use    
0-7 days Ref - - 
≥8 days 2.47 1.12-5.45 0.03 
Table 6: Hazard ratios for EVD infection rate using Cox regression model 
* Cox regression model adjusted for age and sex based on 441 EVDs where date of exit 
(infection, death or 30 days) was available 
 
Paediatric sub-analysis 
Among the 37 catheters inserted into patients aged <18, there were 3 infections giving the 
paediatric cohort an infection rate of 8.1%.  The distribution of pathologies between adult and 
paediatric cases are shown in Table 7. There was a significant (p<0.01) difference in the 
pathological aetiology necessitating an EVD insertion between the different age groups. 
Similarly, there was a significant difference of the catheter types inserted into the two 
cohorts. Particularly, antibiotic-impregnated catheters were preferred in the paediatric cohort 
constituting 62.2% of catheters compared to only 36% of catheters in adults. Importantly, 
exclusion of the paediatric sub-cohort did not cause a change in the observed association 
trends in the Cox Regression analysis. Catheter drainage >8 days and sampling frequency 
(Daily and Alternate days) remained significantly associated with increased ERI risk.  
 
 Paediatrics  Adults p-value 
Pathology   <0.01 
Congenital 4 (10.8) 8 (1.8)  
Shunt dysfunction 3 (8.1) 16 (3.5)  
Neurovascular 8 (21.6) 313 (68.4)  
Other 3 (8.1) 17 (3.7)  
Trauma 5 (13.5) 30 (6.6)  
Tumour 14 (37.8) 74 (16.2)  
Catheter types   <0.01 
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Conventional 5 (13.5) 156 (34.1)  
Antibiotic-impregnated 23 (62.2) 165 (36.0)  
Silver-bearing 9 (24.3) 137 (29.9)  
Table 7: Comparison between paediatric and adult cohort pathology and EVD type.  
 
Mortality and functional outcome 
There were 114 (25.2%) deaths observed within 30 days after EVD insertion in the 452 
patients recruited in our study (Table 5). Of the surviving patients, 164 (48.5%) had a good 
functional outcome (mRS 0-2) and 174 (51.5%) had a poor outcome (mRS 3-4).   
 17 
DISCUSSION 
Utilizing a network of neurosurgical trainees and the BNTRC infrastructure, we were able to 
capture data on a national level and provide the largest prospective multi-centre observational 
study of EVD management and infection rate in the literature. We confirmed 46 ERIs from 
495 catheters giving an infection risk of 9.3% (or 9.8 ERIs per 1000 catheter days). This falls 
within the wide range of quoted infection risk within the literature, however direct 
comparison is limited due to the differing definitions of ERIs used. We chose a pragmatic 
definition which included culture positive CSF or other features of ERI (CSF pleocytosis, 
raised inflammatory markers, clinical features of meningitis) that prompted treatment. This 
definition is used in a range of studies including a previously published randomised trial  
assessing the effectiveness of silver-bearing catheters.[21] A meta-analysis by Ramanan and 
colleagues looked at ERIs and found a total of 35 observational studies reported an overall 
infection rate of 11.4 ERIs per 1000 catheter days.[4] Within their study, the authors found 
several definitions of infection rates used by the 35 studies and the pragmatic definition used 
in our study was the second most utilized definition (7 studies). The meta-analysis of these 7 
studies found a total of 17 ERIs per 1000 catheter days (95% CI 10-24.1). This value was 
double our findings of 9.8 ERIs per 1000 catheter days. This comparison, despite its 
limitations, reflects that the UK and Ireland’s ERI rate is consistent with the literature and 
may be lower than studies with an equivalent ERI definition.  
 
One of our key findings was an increased ERI rate with a longer duration of EVD placement. 
Catheters in-situ for ≥8 days were associated with a greater than two-fold increase in rate of 
developing an ERI compared to those in place for 7 days or less. The literature has 
conflicting evidence on the relationship between the length of EVD placement and ERI. 
Some studies have shown no association with duration of EVD placement and ERI,[22] while 
others corroborated our findings.[7,8] Moreover, some authors have recommended routine 
replacement of EVDs,[23] while others argue against this.[6] Wong and colleagues 
interrogated this question in a small RCT where they compared routine EVD change (every 5 
days) to no change.[24] The study found no difference in ERIs but a trend to higher infection 
in the routine change group; the authors advised against the use of regular pre-emptive EVD 
replacement. Our data also showed that an increased frequency of CSF sampling was found 
to be a significant parameter associated with ERI risk. In keeping with this, several studies 
have found that patients with an ERI were sampled more frequently than those without an 
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ERI.[6,7] Their statistical approaches may have been biased by the fact that the number of 
CSF samples increased with the duration of EVD placement. Our approach did not use 
absolute numbers of samples taken but rather the sampling frequency protocol. Though this 
approach has its benefits, we are unable to conclude a direct causal relationship between 
sampling frequency and ERI. When assessed in the Cox Regression Model, we found that 
both catheter duration and sampling frequency were associated with a significantly higher 
ERI risk. Based on the literature and our data, we conclude that catheters should be removed 
as early as possible and a lower frequency sampling protocol should be considered as this 
may help reduce ERI risk. 
 
The development of antimicrobial impregnated catheters (both antibiotic- and silver-bearing 
catheters) has been a major approach for combating ERI risk. The most commonly used 
antibiotic-impregnated catheters contain clindamycin and rifampicin, while the silver-bearing 
catheters contain silver nanoparticles. These catheters impede and kill bacteria with the goal 
of reducing ERI risk and several studies have attempted to assess their effectiveness. Despite 
heterogeneity, meta-analyses of these data have broadly pointed towards the effectiveness of 
impregnated catheters compared to plain catheters.[9,10] Interestingly, our study showed that 
despite this body of evidence, almost a third of catheters inserted in the UK and Ireland were 
plain catheters. Our study also failed to demonstrate a significant difference in infection risk 
between the three different catheter types after adjusting for a range of clinical variables, 
although there was a trend towards silver-bearing catheters having the highest ERI rate.  This 
is in contrast to a previous trial that suggest silver-bearing catheters are more effective than 
plain[21].  In meta-analyses, antibiotic-impregnated catheters have shown more pronounced 
reductions in ERI risk compared to plain catheters when compared to reductions of risk seen 
in silver versus plain catheters.[9,10] This reflects evidence from central venous catheters 
that found superiority of antibiotic-impregnated catheters compared to those coated with 
silver in reducing bloodstream infections.[25] In the UK and Ireland,  a major multi-centre 
RCT (The British Antibiotic and Silver Impregnated Catheters for ventriculoperitoneal 
Shunts trial; BASICS trial) is currently under way aiming to assess the comparative efficacy 
of antibiotic-, silver-bearing and plain catheters in reducing CSF infections for patients with a 
ventriculoperitoneal shunt.[26] The results of this trial will be of great interest to the field and 
help guide future trial designs looking at a similar question in EVD care. While our data does 
not support the routine use of antibiotic- and silver-bearing EVD catheters to reduce ERI risk, 
it highlights an important cost implication that warrants further study since antibiotic- and 
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silver-bearing catheters are substantially more expensive.  
 
In our study, the majority of cultured organisms were gram positive (68.9%) and 
staphylococci were the most common agent (55.1%). The predominance of staphylococci 
mirrors other findings in the literature.[7,8,27] Most cultured organisms from all three 
catheter types were gram positive organisms: plain catheters (63.6%), antibiotic-impregnated 
catheters (87.5%) and silver-bearing catheters (60%). These findings run counter to trends 
described in the literature of a shift towards gram negative organisms.[6,12,28] A range of 
explanations has been proposed including the impact of antimicrobial impregnated catheters. 
In vitro investigation of silver-bearing catheters found a greater eradication of S. epidermidis 
compared to E. coli.[29] It is of interest that in our data the two cases of Enterobacter were in 
patients with antibiotic-impregnated and silver-bearing catheters. Atkinson and colleagues 
concluded that their observed increase in gram negative organisms was related to the use of 
silver-bearing catheters, however their small sample placed limitations on this conclusion.[6] 
Prolonged systemic prophylactic antibiotics during drainage has also been implicated in a 
shift towards more gram negative microorganisms.[28,30] In our study, only a small 
percentage (3.2%) of cases received prolonged systemic antibiotics which may, in part, 
explain the dominance of gram positive organisms.  
 
This study has a number of limitations. Firstly, we were unable to confirm case ascertainment 
in individual neurosurgical units. In part, this was due to the nature of rotational 
neurosurgical training which meant trainees would move units; not allowing for continuous 
data collection in some units. This may have led to an underreporting of inserted EVDs 
which could have led to bias in the results. Secondly, our choice of ERI definition could be 
open to criticism as it places an onus on the managing clinician to determine the presence of 
ERIs in cases without a positive CSF culture. This may overestimate the number of ERIs in 
our cohort due to the presence of false positives. However, as argued above, we believe that 
the definition is pragmatic, holds relevance for day-to-day clinical practice and has been used 
in previous RCTs.[21] Thirdly, neurosurgical units may have different protocols for EVD 
management that influence the risk of ERIs. In particular, a strict infection control protocol 
for manipulation of EVD is shown to be associated with a lower risk of ERIs.[31,32] Local 
EVD management protocols may confound the results shown in our study. This confounding 
effect is not likely to have had a large impact on our results since our sensitivity analysis did 
not show a significant difference in local infection rates, but this aspect of EVD care should 
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be taken into account when interpreting the results. Coupled to this, we did not capture data 
on concomitant infections which may act as a confounder. Within the data, we also found a 
significant difference in mortality between catheter subtypes. Though an interesting finding, 
our study was not designed to examine this question and caution should be taken in drawing 
conclusions around this observation which is at risk of confounders. Finally, many 
neurosurgical units favour a single catheter type for EVD insertion. Therefore, factors 
specific to individual units which contribute to infection rate may confound the overall 
infection risk difference between the three catheter subtypes. While we did not demonstrate a 
significant difference between the catheter subtypes, the ERIs between the three groups 
allows us to perform adequate power calculations for future randomised trials.  
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CONCLUSIONS 
This study demonstrated an ERI rate of 9.3% in 21 centres in the UK and Ireland with a 
predominance of gram positive organisms. Patients with an EVD left in situ for ≥8 days and 
who underwent more frequent sampling had a higher risk of infection. Importantly, there was 
wide variation in the choice of catheter across the country with no significant difference in 
ERI risk between the types. These findings support the need for a prospective clinical trial to 
assess the comparative effectiveness of EVD catheter type on ERI risk.  
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FIGURES LEGENDS 
Figure 1: Nelson-Aalen cumulative hazard estimate of EVD infection by (A) Type of EVD 
catheter: Log-rank test of equality showed p=0.06 (B) Catheter duration: Log-rank test of 
equality showed p<0.01 (C) Tunnelling length: Log-rank test of equality showed p=0.41. 
 
 
